About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Psoriasis Clinical Trials in New York | 7 Studies

Clinical Trials PsoriasisNew York

Psoriasis Clinical Trials in New York

Find 7 clinical trials for psoriasis near New York, New York. Connect with research centers in your area.

All Psoriasis trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-7 of 7 trials

RecruitingObservational Study of Pediatric Rheumatic Diseases: The CARRA RegistryContinuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases.NCT02418442·Birmingham, Alabama and 81 others

Psoriasis Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF InhibitorsTo examine the safety and efficacy of tofacitinib in subjects with active psoriatic arthritis who have previously had an inadequate response to at least one TNF inhibitor either…NCT01882439·Birmingham, Alabama and 124 others

CompletedPatterns After Administration of MCFAs in Psoriasis and Psoriatic ArthritisThis is a proof-of-principle, placebo-controlled, open label study to assess the improvement in the Treg counts and PASI Scores with PEVCO given at 1000 mg four times daily in…NCT03409211·New York, New York

CompletedEfficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.This clinical study will test the effects of a drug called apremilast in oligoarticular psoriatic arthritis with less than 5 years of disease duration.NCT03747939·Mesa, Arizona and 113 others

RecruitingGuselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsThe trial is an open-label randomized study that will examine whether switching to a selective IL23 inhibitor (guselkumab) is more effective than switching to a second TNFi…NCT05669833·Loxahatchee Groves, Florida and 13 others

CompletedOpen-Label Extension Study Of Tofacitinib In Psoriatic ArthritisThis is a Phase 3, long-term open-label extension study to evaluate the safety, tolerability and efficacy of tofacitinib in subjects with active PsA who have previously…NCT01976364·Birmingham, Alabama and 152 others

CompletedEfficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator StudyThis is a 12-month study investigating the effectiveness and safety of tofactinib in treating the signs and symptoms of active psoriatic arthritis and improving physical function…NCT01877668·Birmingham, Alabama and 122 others

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia